Doximity Inc. [DOCS] moved down -4.52: Why It’s Important

Related

Doximity Inc. [NYSE: DOCS] loss -4.52% on the last trading session, reaching $46.91 price per share at the time. The company report on November 17, 2021 that Doximity to Participate in Upcoming Investor Events.

Doximity Executives To Take Part in Piper Sandler Healthcare Conference, Raymond James Technology Conference.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will participate in virtual fireside chats at the following upcoming investor events.

Doximity Inc. represents 186.17 million in outstanding shares, while the company has a total market value of $8.97 billion with the latest information. DOCS stock price has been found in the range of $44.54 to $49.82.

If compared to the average trading volume of 2.83M shares, DOCS reached a trading volume of 2788711 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Doximity Inc. [DOCS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DOCS shares is $72.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DOCS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for Doximity Inc. shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on December 14, 2021. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on December 02, 2021, representing the official price target for Doximity Inc. stock. Previously, the target price had yet another raise to $84, while Robert W. Baird analysts kept a Outperform rating on DOCS stock. On November 10, 2021, analysts increased their price target for DOCS shares from 68 to 81.

The Average True Range (ATR) for Doximity Inc. is set at 3.93, with the Price to Sales ratio for DOCS stock in the period of the last 12 months amounting to 32.32. The Price to Book ratio for the last quarter was 11.30, with the Price to Cash per share for the same quarter was set at 3.88.

Trading performance analysis for DOCS stock

Doximity Inc. [DOCS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.24. With this latest performance, DOCS shares dropped by -24.23% in over the last four-week period, additionally sinking by -11.05% over the last 6 months .

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DOCS stock in for the last two-week period is set at 35.44, with the RSI for the last a single of trading hit 31.80, and the three-weeks RSI is set at 37.76 for Doximity Inc. [DOCS]. The present Moving Average for the last 50 days of trading for this stock 60.84, while it was recorded at 49.81 for the last single week of trading.

Doximity Inc. [DOCS]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Doximity Inc. [DOCS] shares currently have an operating margin of +26.00 and a Gross Margin at +84.92. Doximity Inc.’s Net Margin is presently recorded at +10.42.

Return on Total Capital for DOCS is now 45.92, given the latest momentum, and Return on Invested Capital for the company is 18.63. Return on Equity for this stock inclined to 18.68, with Return on Assets sitting at 10.92. When it comes to the capital structure of this company, Doximity Inc. [DOCS] has a Total Debt to Total Equity ratio set at 0.85. Additionally, DOCS Total Debt to Total Capital is recorded at 0.84, with Total Debt to Total Assets ending up at 0.49. Long-Term Debt to Equity for the company is recorded at 0.43, with the Long-Term Debt to Total Capital now at 0.19.

Receivables Turnover for the company is 5.41 with a Total Asset Turnover recorded at a value of 1.05.Doximity Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.70 and a Current Ratio set at 8.70.

>> 7 Top Picks for the Post-Pandemic Economy <<

An analysis of insider ownership at Doximity Inc. [DOCS]

There are presently around $1,472 million, or 48.60% of DOCS stock, in the hands of institutional investors. The top three institutional holders of DOCS stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 5,156,496, which is approximately 21.483% of the company’s market cap and around 1.10% of the total institutional ownership; VANGUARD GROUP INC, holding 4,193,557 shares of the stock with an approximate value of $206.03 million in DOCS stocks shares; and WHALE ROCK CAPITAL MANAGEMENT LLC, currently with $193.21 million in DOCS stock with ownership of nearly 77.924% of the company’s market capitalization.

Positions in Doximity Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 109 institutional holders increased their position in Doximity Inc. [NYSE:DOCS] by around 12,564,655 shares. Additionally, 71 investors decreased positions by around 6,856,076 shares, while 8 investors held positions by with 10,535,445 shares. The mentioned changes placed institutional holdings at 29,956,176 shares, according to the latest SEC report filing. DOCS stock had 84 new institutional investments in for a total of 4,121,709 shares, while 52 institutional investors sold positions of 3,369,067 shares during the same period.